Daphne Quimi, Director at Century Therapeutics, Inc. (IPSC), bought 5,000 shares at $1.53 ($8K) on 2024-09-12, disclosed to the SEC on 2024-09-16.
Open-market purchase of $8k IPSC by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| FOLD | SELL | 2022-09-06 | $50K | — | Filing → |
| FOLD | SELL | 2022-08-09 | $70K | — | Filing → |
| FOLD | SELL | 2022-06-21 | $40K | — | Filing → |